This FDA InspectorProfile is a report of relevant audit-related information on Lindsey Schwierjohann, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Lindsey Schwierjohann's inspections in 7 countries: United States, Italy, China, Belgium, Japan, Austria, and Taiwan.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Lindsey Schwierjohann's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Lindsey Schwierjohann.
Note: The EIR and 483 documents are sold separately.